登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，3月17日，Coronavirus latest: First vaccine clinical trials begin in United States》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-18

  • 17 March 00:30 GMT — First vaccine clinical trials begin in the United States

    The first phase I clinical trial for a potential COVID-19 vaccine has begun in Seattle, Washington.

    Four adults, the first of 45 eventual participants, received their first doses of an experimental vaccine developed through a partnership between the US National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, a biotechnology company based in Cambridge, Massachusetts. But although it is an important milestone, the phase I trial is just the beginning of a long process to test the drug’s safety and efficacy.

  • 原文来源：https://www.nature.com/articles/d41586-020-00154-w
19浏览量
原文链接
相关报告

  • 《Nature，3月18日，Coronavirus vaccines: five key questions as trials begin》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-19
    • The push to make a coronavirus vaccine is moving at breakneck speed. This week, the first of a few dozen healthy volunteers in Seattle, Washington, received a vaccine in a phase 1 safety trial sponsored by the US government. Similar safety trials of other coronavirus vaccines will also begin soon.
    17浏览量
    原文链接

  • 《Nature，4月23日，Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-24
    • Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States The COVID-19 Investigation Team Nature Medicine (2020) Abstract Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological and virological characteristics are limited. In this case series, we describe the first 12 US patients confirmed to have COVID-19 from 20 January to 5 February 2020, including 4 patients described previously1,2,3. Respiratory, stool, serum and urine specimens were submitted for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (rRT-PCR) testing, viral culture and whole genome sequencing. Median age was 53 years (range: 21–68); 8 patients were male. Common symptoms at illness onset were cough (n = 8) and fever (n = 7). Patients had mild to moderately severe illness; seven were hospitalized and demonstrated clinical or laboratory signs of worsening during the second week of illness.
    66浏览量
    原文链接